Effect of esomeprazole on intragastric pH in healthy Chinese with different CYP2C19 genotypes

仲珑瑾,程能能,李兆申,陈斌艳,王永铭

DOI: https://doi.org/10.3969/j.issn.1007-4406.2004.03.001

2004-01-01

Abstract:AIM: To examine whether the effect of esomeprazole (Eso) on intragastric pH depends on CYP2C19genotype status. METHODS: CYP2C19 genotype status for 2 mutations associated with the poor metabolizer phenotype was determined by a polymerase chain reaction-restriction fragnment length polymorphism (PCR-RFLP) method in 27healthy Chinese volunteers. After 5 days' administration of Eso 40 mg, po, qd, intragastric pH values were monitored for 24 h on both d 1 and d 5 of the study period. RESULTS: The 27 subjects were divided into 3 genotype groups including 10 homozygous extensive metabolisers (homEMs), 14 heterozygous extensive metabolisers (hetEMs) and 3 poor metabolisers (PMs) according to PCR-RFLP analysis. Oral administration of either a single dose of Eso 40 mg or repeated doses of Eso 40 mg once daily for 5 d did not produce statistically significant difference in the mean 24 h median pH values among the 3 genotype groups. With respect to the percentage of 24-hour monitoring period with pH ＞ 4, PMs showed about 20% longerduration of effect than homEMs and hetEMs on both d 1 and d 5 after dosing (P＜0.05), while hetEMs was not significantly different from homEMs. CONCLUSION: The acid inhibitory effect of Eso is similar in potency among the subjects with different CYP2C19 genotypes, though different in duration between EMs and PMs.